U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07089303) titled 'Alzheimer's Disease Multinuclear Imaging Neuro-Enhanced Resolution (AD-MINER)' on July 20.
Brief Summary: This single-center prospective cohort study will enroll 750 participants (250 cognitively normal individuals, 250 with mild cognitive impairment, and 250 with Alzheimer's disease). At baseline and at annual follow-ups, participants will undergo 3 T and 7 T multimodal MRI scans, blood biomarker testing, genotyping, and cognitive assessments to identify early imaging biomarkers and construct models of disease progression.
Study Start Date: July, 2025
Study Type: OBSERVATIONAL
Condition:
Alzheimer's Disease(AD)
7T MR
23Na MR
R...